EUCTR2004-001362-40-IT进行中（未招募）不适用
PHASE II STUDY OF IMATINIB MESYLATEIN CHORDOMA
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Efficacy and Safety of Imatinib in ChordomaChordomaNCT00150072Novartis Pharmaceuticals55
进行中（未招募）
不适用
A Phase II Trial to Evaluate the Activity of Imetelstat (GRN163L) in Patients with Essential Thrombocythemia who Require Cytoreduction and Have Failed or Are Intolerant to Previous Therapy, or who Refuse Standard TherapyMedDRA version: 16.0Level: PTClassification code 10015493Term: Essential thrombocythaemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Essential thrombocythemiaEUCTR2010-023076-10-DEGeron Corporation40
进行中（未招募）
不适用
ETUDE DE PHASE II DU THALIDOMIDE DANS LES MASTOCYTOSESEUCTR2006-005087-10-FRCHU Amiens
进行中（未招募）
1 期
IMM101 treatment, combined with CyberKnife, in Colorectal CancerMetastatic colorectal cancerMedDRA version: 14.0 Level: PT Classification code 10061451 Term: Colorectal cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-003958-85-GBImmodulon Therapeutics Ltd12
进行中（未招募）
不适用
IMATINIB MESYLATE IN ADVANCED LOW GRADE SOLID TUMORS EXPRESSING IMATINIB MESYLATE TARGETS - NDEUCTR2008-000688-41-ITISTITUTO EUROPEO DI ONCOLOGIA